Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity

Journal of Medicinal Chemistry

Volumn 45, Issue 15, 2002, Pages 3171-3183

  Bertrand, Hugues Olivier ^a   Bessis, Anne Sophie ^b   Pin, Jean Philippe ^c   Acher, Francine C ^b  

^a Parc Club Orsay Universite   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPENTANE 1,3,4 TRICARBOXYLIC ACID; 2 AMINO 4 PHOSHONOBUTYRIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; 4 CARBOXYPHENYLGLYCINE; 4 PHOSPHONOPHENYLGLYCINE; CYCLOPROPANE DERIVATIVE; DICARBOXYCYCLOPROPYLGLYCINE; EGLUMETAD; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR AGONIST; QUISQUALIC ACID; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR STABILITY;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; LIGANDS; MODELS, MOLECULAR; RECEPTORS, METABOTROPIC GLUTAMATE; SEQUENCE HOMOLOGY, AMINO ACID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037130210     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010323l     Document Type: Article

References (62)

1. Neurological disorders
2. Pharmacology and functions of metabotropic glutamate receptors
3. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system
4. Type III family of GPCRs - Metabotropic glutamate receptors
5. New perspective in the development of selective metabotropic glutamate receptor ligands
6. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
7. Ligands for glutamate receptors: Design and therapeutic prospects
8. The metabotropic glutamate receptors: Structure, activation mechanism and pharmacology
9. Comparative effect of L-CCG-I, DCG-IV and 7-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes
10. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties
11. Synthesis, pharmacological characterization, and molecular modeling of hetero bicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]-hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, systemically active agonists for group II metabotropic glutamate receptors
12. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo [3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists
13. Synthesis and pharmacological characterization of aminocyclopentane tricarboxylic acids (ACPT): New tools to discriminate between metabotropic glutamate receptor subtypes
14. Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor
15. (+)-Phosphonophenylglycine (PPG): A new group III selective metabotropic glutamate receptor agonist
16. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord
17. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: A different environment but similar recognition of an extended glutamate conformation
18. Extended glutamate activates metabotropic receptor types 1, 2 and 4: Selective features at mGluR4 binding site
19. Three-dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: New insights into the activation process
20. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
21. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins
22. Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor
23. Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+
24. Structural mechanisms for domain movements in proteins
25. Metabotropic glutamate receptor is a disulfide-linked dimer
26. Allosteric modulators of group I metabotropic glutamate receptors: Novel subtype-selective ligands and therapeutic perspectives
27. A model for the functioning of family 3 GPCRs
28. 3H]-L-2-Amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a
29. 2 receptor-transfected cell membranes
30. 3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: Characterization of binding to membranes of mGlu receptor subtype expressing cells
31. 3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes
32. 3H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections
33. 3H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors
34. 3H]-CPPG
35. Very empirical treatment of solvation and entropy: A force field derived from log Po/w
36. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
37. Cation-II interactions in structural biology
38. The CH/II interaction: Significance in molecular recognition
39. Binding of small organic molecules to macromolecular targets: Evaluation of conformational entropy changes
40. Virtual screening for bioactive molecules: Understanding receptor ligand interactions as prerequisite for virtual screening
41. Edge-to-face CH/II interaction between ligand Phe-Phenyl and receptor aromatic group in the thrombin receptor activation
42. Ab initio study of hydrogen-bonded complexes of small organic molecules with water
43. New probes of the agonist binding site of metabotropic glutamate receptors
44. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming
45. A general and fast scoring function for protein-ligand interactions: A simplified potential approach
46. Statistical potentials and scoring functions applied to protein-ligand binding
47. Evaluation of docking/scoring approaches: A comparative study based on MMP3 inhibitors
48. A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities
49. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core
50. Periplasmic binding protein structure and function. Refined x-ray structures of the leucine/isoleucine/valine-binding protein and its complex with leucine
51. Structure of the L-leucine-binding protein refined at 2.4 A resolution and comparaison with the Leu/Ile/Val-binding protein structure
52. Conservation of the ligand recognition site of metabotropic glutamate receptors during evolution
53. 2+-sensing receptor
54. Functional identification of a goldfish odorant receptor
55. Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm
56. The particle concept: Placing discrete water molecules during protein-ligand docking predictions
57. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site
58. Atomic structure and specificity of bacterial periplasmic receptors for active transport and chemotaxis: Variation of common themes
59. Definition of general topological equivalence in protein structures: A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming
60. Assessment of protein models with three-dimensional profiles
61. Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor